Skip to main content
Publication date
2017 11
Authors
Kumar, SK Dimopoulos, MA Kastritis, E Terpos, E Nahi, H Goldschmidt, H Hillengass, J Leleu, X Beksac, M Alsina, M Oriol, A Cavo, M Ocio, EM Mateos, MV O'Donnell, EK Vij, R Lokhorst, HM van de Donk, NWCJ Min, C Mark, T Turesson, I Hansson, M Ludwig, H Jagannath, S Delforge, M Kyriakou, C Hari, P Mellqvist, U Usmani, SZ Dytfeld, D Badros, AZ Moreau, P Kim, K Otero, PR Lee, JH Shustik, C Waller, D Chng, WJ Ozaki, S Lee, JJ de la Rubia, J Eom, HS Rosinol, L Lahuerta, JJ Sureda, A Kim, JS Durie, BGM
Author KI Usernames
Nahi, H|harnah
Pubmed ID
28620163
Journal
Leukemia
Doctype
Article
KI Connection
Låg
Mesh SV
Immunmodulerande medel Kohortstudier Kvinnlig Manlig Medelålders personer Multipelt myelom Människa Prognos Proteasomblockerare Vuxna Återfall Äldre Äldre, 80 och över Överlevnadsanalys
Mesh EN
Adjuvants, Immunologic Cohort Studies Multiple Myeloma Prognosis Proteasome Inhibitors Recurrence Survival Analysis
First date
2017-11-12T10:42:49.085Z